← Every company
Takeda Pharmaceutical Co Ltd SEC Filings
What Takeda Pharmaceutical Co Ltd has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
TAK overview →Filings on file
10
since Jan 19, 2017
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jun 17, 2026 | Annual report 20-F | Read ↗ |
| Jun 25, 2025 | Annual report 20-F | Read ↗ |
| Jun 26, 2024 | Annual report 20-F | Read ↗ |
| Jun 28, 2023 | Annual report 20-F | Read ↗ |
| Jun 29, 2022 | Annual report 20-F | Read ↗ |
| Jun 29, 2021 | Annual report 20-F | Read ↗ |
| Jun 24, 2020 | Annual report 20-F | Read ↗ |
| Jun 27, 2019 | Annual report 20-F | Read ↗ |
| Apr 30, 2018 | Tender offer SC TO-T | Read ↗ |
| Jan 19, 2017 | Tender offer SC TO-T | Read ↗ |
Source: Takeda Pharmaceutical Co Ltd's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on TAK
Company overviewEverything on TAK in one place, with the price.Insider tradingWhat TAK's own officers and directors buy and sell.Who owns itEvery manager reporting a position in TAK.Funds holding itWhich funds and ETFs hold TAK, and how big a bet.LobbyingWhat TAK spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on TAK's account, and who they worked for.PatentsWhat TAK is filing at the patent office.